Literature DB >> 22094557

Emerging pathogenetic mechanisms of the implant-related osteomyelitis by Staphylococcus aureus.

Lucio Montanaro1, Francesca Testoni, Alessandro Poggi, Livia Visai, Pietro Speziale, Carla Renata Arciola.   

Abstract

Implant-related osteomyelitis is a severe and deep infection of bone that arises and develops all around an implant. Staphylococcus aureus is the first cause of osteomyelitis, whether implant-related or not. Bone is an optimal substratum for S. aureus, since this bacterium expresses various adhesins by which can adhere to bone proteins and to the biomaterial surfaces coated with the proteins of the host extracellular matrix. S. aureus is able not only to colonize bone tissues, but also to invade and disrupt them by entering bone cells and inducing cell death and osteolysis. Here we illustrate the pathogenetic mechanisms that can explain how the osteomyelitis sets in and develops around an implant.

Entities:  

Mesh:

Year:  2011        PMID: 22094557     DOI: 10.5301/ijao.5000052

Source DB:  PubMed          Journal:  Int J Artif Organs        ISSN: 0391-3988            Impact factor:   1.595


  22 in total

Review 1.  Nanostructured platforms for the sustained and local delivery of antibiotics in the treatment of osteomyelitis.

Authors:  Vuk Uskokovic
Journal:  Crit Rev Ther Drug Carrier Syst       Date:  2015       Impact factor: 4.889

2.  Contribution of Reduced Interleukin-10 Levels to the Pathogenesis of Osteomyelitis in Children with Sickle Cell Disease.

Authors:  Sameh Sarray; Wassim Y Almawi
Journal:  Clin Vaccine Immunol       Date:  2015-07-01

3.  Immunomodulatory Peptide IDR-1018 Decreases Implant Infection and Preserves Osseointegration.

Authors:  Hyonmin Choe; Arvind S Narayanan; Deep A Gandhi; Aaron Weinberg; Randall E Marcus; Zhenghong Lee; Robert A Bonomo; Edward M Greenfield
Journal:  Clin Orthop Relat Res       Date:  2015-09       Impact factor: 4.176

4.  Dense cancellous bone as evidenced by a high HU value is predictive of late implant failure: a preliminary study.

Authors:  Ikuya Miyamoto; Tetsu Takahashi; Tatsurou Tanaka; Bunichi Hirayama; Kenko Tanaka; Toru Yamazaki; Yasuhiro Morimoto; Izumi Yoshioka
Journal:  Oral Radiol       Date:  2017-08-03       Impact factor: 1.852

5.  Osteogenic and antimicrobial nanoparticulate calcium phosphate and poly-(D,L-lactide-co-glycolide) powders for the treatment of osteomyelitis.

Authors:  Vuk Uskoković; Charles Hoover; Marija Vukomanović; Dragan P Uskoković; Tejal A Desai
Journal:  Mater Sci Eng C Mater Biol Appl       Date:  2013-04-13       Impact factor: 7.328

Review 6.  Nanomaterials and synergistic low-intensity direct current (LIDC) stimulation technology for orthopedic implantable medical devices.

Authors:  Rohan A Shirwaiker; Meghan E Samberg; Paul H Cohen; Richard A Wysk; Nancy A Monteiro-Riviere
Journal:  Wiley Interdiscip Rev Nanomed Nanobiotechnol       Date:  2013-01-17

7.  Retention of the well-fixed implant in the single-stage exchange for chronic infected total hip arthroplasty: an average of five years of follow-up.

Authors:  Baochao Ji; Boyong Xu; Wentao Guo; Aili Rehei; Wenbo Mu; Desheng Yang; Li Cao
Journal:  Int Orthop       Date:  2016-09-20       Impact factor: 3.075

8.  In Vivo MicroCT Monitoring of Osteomyelitis in a Rat Model.

Authors:  Vincent A Stadelmann; Inga Potapova; Karin Camenisch; Dirk Nehrbass; R Geoff Richards; T Fintan Moriarty
Journal:  Biomed Res Int       Date:  2015-04-29       Impact factor: 3.411

9.  Staphylococcus aureus biofilms decrease osteoblast viability, inhibits osteogenic differentiation, and increases bone resorption in vitro.

Authors:  Carlos J Sanchez; Catherine L Ward; Desiree R Romano; Brady J Hurtgen; Sharanda K Hardy; Ronald L Woodbury; Alex V Trevino; Christopher R Rathbone; Joseph C Wenke
Journal:  BMC Musculoskelet Disord       Date:  2013-06-14       Impact factor: 2.362

10.  Ultrasound Triggered Drug Release from Affinity-Based β-Cyclodextrin Polymers for Infection Control.

Authors:  Smriti Bohara; Nathan Rohner; Emily Budziszewski; Jackrit Suthakorn; Horst A von Recum; Agata A Exner
Journal:  Ann Biomed Eng       Date:  2021-06-25       Impact factor: 4.219

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.